Skip to main content
All lobbying filings

THE ERISA INDUSTRY COMMITTEE

THE ERISA INDUSTRY COMMITTEE filed a Q2 report for ERISA INDUSTRY COMMITTEE on July 17, 2025.

Lobbying for ERISA INDUSTRY COMMITTEE

All filings by THE ERISA INDUSTRY COMMITTEE · Everything ERISA INDUSTRY COMMITTEE has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 17, 2025
Expenses
$86,195
What this organization spent lobbying with its own staff. Reported using IRS section 162(e) definitions (method C): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 2
  • MELISSA BARTLETT New on this filing
    Previously held: Privacy Program Specialist, U.S. Department of Health and Human Services, Office of the Secretary, Office for Civil Rights Counsel, U.S. House of Representatives, Committee on Energy and Commerce
  • ANDREW BANDUCCI
    Previously held: Professional Staff Member and Workforce Policy Counsel, House Comm. on Education and the Workforce;Labor and Pensions Policy Director, Sen. HELP Comm.;Chief Policy Officer, Pension Benefit Guaranty Corp;Pensions Detailee, Sen. Finance Comm.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 18

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3
Health Issues

Affordable Care Act, all provisions and related regulations, including employer mandate, wellness issues, out-of-pocket (OOP) limits, and nondiscrimination PCORI & comparative effectiveness, coverage mandates on ERISA plans, access to preventive care items and services ADA and GINA, HIPAA compliance, privacy and security of health information, access to claims data, and all payers claims databases Cybersecurity, artificial intelligence Coverage of and access to mental health and substance use disorder treatment Tax treatment of employer-sponsored benefits and insurance Patent reforms, prescription drug costs, rebates, generics, and biosimilars, Rx supply chain, medical management, value-driven care in public and private coverage, patient safety and quality Medicare Advantage, Medicare secondary payer, end stage renal disease (ESRD), and retiree health, COBRA, Medicare expansion and public option Health savings accounts and high-deductible health plan modernization ERISA preemption, plan administration, electronic delivery Transparency and accountability in the health care system, vertical integration impacts on health care Caregiving, surprise medical billing, hospital billing, consolidation, anti-competitive practices Telehealth expansion, interstate provider licensing

Retirement

Paid leave issues Emergency savings Single-employer defined benefit issues Retirement plan disclosures Retirement plan investment requirements, options, duties, and related issues Retirement plan contribution flexibility Modernizing retirement plan administration Retirement plan recordkeeping issues PBGC premiums SECURE 2.0 Act implementation Multiemployer pensions Litigation and enforcement affecting benefit plans Retirement plan coverage Retirement incentives

Taxation/Internal Revenue Code

Tax treatment of employer-sponsored health benefits Modernizing high-deductible health plans (HDHPs)/health savings accounts(HSAs) Treatment of 1st-dollar coverage of HDHP/HSA telehealth services, excepted benefits for stand-along telehealth plans Retirement-related tax issues

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem